Genelink Inc (GNLKQ)
0.00
USD |
OTCM |
Nov 13, 16:00
Genelink Total Liabilities (Quarterly): 4.488M for Sept. 30, 2013
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2013 | 4.488M |
June 30, 2013 | 4.368M |
March 31, 2013 | 4.251M |
December 31, 2012 | 4.116M |
September 30, 2012 | 5.595M |
June 30, 2012 | 4.418M |
March 31, 2012 | 4.127M |
December 31, 2011 | 4.261M |
September 30, 2011 | 2.669M |
June 30, 2011 | 2.716M |
March 31, 2011 | 2.607M |
December 31, 2010 | 2.511M |
September 30, 2010 | 2.754M |
June 30, 2010 | 2.599M |
March 31, 2010 | 2.830M |
December 31, 2009 | 2.621M |
September 30, 2009 | 2.656M |
June 30, 2009 | 2.413M |
March 31, 2009 | 2.348M |
December 31, 2008 | 2.493M |
September 30, 2008 | 4.218M |
June 30, 2008 | 1.853M |
March 31, 2008 | 1.270M |
December 31, 2007 | 1.190M |
September 30, 2007 | 1.542M |
Date | Value |
---|---|
June 30, 2007 | 2.050M |
March 31, 2007 | 1.897M |
December 31, 2006 | 1.408M |
September 30, 2006 | 1.639M |
June 30, 2006 | 1.579M |
March 31, 2006 | 1.254M |
December 31, 2005 | 1.058M |
September 30, 2005 | 1.126M |
June 30, 2005 | 0.8663M |
March 31, 2005 | 0.7905M |
December 31, 2004 | 0.7646M |
September 30, 2004 | 0.7243M |
June 30, 2004 | 0.5519M |
March 31, 2004 | 0.6048M |
December 31, 2003 | 0.4714M |
September 30, 2003 | 0.7475M |
June 30, 2003 | 0.7864M |
March 31, 2003 | 0.7815M |
December 31, 2002 | 0.6813M |
September 30, 2002 | 0.6039M |
June 30, 2002 | 0.5099M |
March 31, 2002 | 0.6075M |
December 31, 2001 | 0.5162M |
September 30, 2001 | 0.5748M |
June 30, 2001 | 0.4828M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
CEL-SCI Corp | 15.60M |
AIM ImmunoTech Inc | 9.613M |
IGC Pharma Inc | 2.714M |
NovaBay Pharmaceuticals Inc | 4.542M |
Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.284M |
Shareholders Equity (Quarterly) | -3.203M |